Novel use of nebulised adrenaline in the treatment of secondary oropharyngeal haemorrhage.
We report the use of nebulised adrenaline in the treatment of secondary oropharyngeal haemorrhage. Cases involving two adults and one child are presented to illustrate the usefulness of this technique in helping to achieve haemostasis without the need for a general anaesthetic. The mechanisms of the haemostatic action of adrenaline are also explored. We believe that in selected cases nebulised adrenaline is both safe, effective and easily tolerated and represents a useful additional tool in the treatment of oropharyngeal haemorrhage.
Rowlands
R G
RG
Department of Otolaryngology, St George's Hospital, London, UK. GRowlands1@aol.com
Hicklin
L
L
Hinton
A E
AE
D000280:Administration, Inhalation; D000293:Adolescent; D000368:Aged; D002675:Child, Preschool; D004837:Epinephrine / Q000008:administration & dosage*; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D009330:Nebulizers and Vaporizers; D009364:Neoplasm Recurrence, Local / Q000150:complications; D009960:Oropharynx; D010608:Pharyngeal Diseases / Q000188:drug therapy* / Q000209:etiology; D019106:Postoperative Hemorrhage / Q000188:drug therapy / Q000209:etiology; D014067:Tonsillar Neoplasms / Q000150:complications; D014068:Tonsillectomy / Q000009:adverse effects; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*
D014662:Vasoconstrictor Agents; D004837:Epinephrine